On the generics and biosimilars front, the combined business is expected to benefit from Sun’s portfolio of more than 550 approved ANDAs across multiple dosage forms
Acquisition to expand the company's women’s health and biosimilars footprint, positioning it among top 25 drugmakers globally
The move brings one of the country’s most widely prescribed blood thinners onto Cost Plus Drug Company’s online pharmacy platform
_256_384.jpg)
The approval makes Cipla’s product the first AB-rated generic therapeutic equivalent of Ventolin HFA
Founded by Amit Patni, the company rolls out 90+ formulations across acute and specialty therapies
The agreements aim to strengthen medicine quality, patient safety and pharmaceutical research in India
The collaboration will roll out an “agentic” AI platform across Merck’s research & development, manufacturing, commercial, and corporate operations
Once complete, the site will serve as AbbVie’s U.S. center of excellence for SVP manufacturing
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
Narasimhan’s appointment underscores the growing importance of AI in transforming drug discovery
Subscribe To Our Newsletter & Stay Updated
